Israel Active

Israel’s Kamada (reported previously) has completed manufacturing the first batch of its plasma-derived Immunoglobulin G (IgG) product for Covid-19 patients. Initial vials of the antibody have been made available for compassionate use in Israel.

Muhammad Khatib, PhD student at Israel’s Technion. has developed a polymer that is strong, water resistant, conducts electricity and is super elastic. Furthermore, when it is cut and put into water it will repair itself! Future applications include robotic skin, prosthetics and wearable devices.

A new video from Israel’s P-Cure (reported previously) that is using its focused proton radiation therapy device to destroy cancer tumors.

New video featuring Magen David Adom’s blood donation service and how vital it is for use in surgical operations and medical research. Also, blood plasma helps patients with compromised immune systems. Finally, construction of the world’s first underground blood bank is proceeding well.

Israel’s Beecardia connects patients, doctors and remote specialists. The startup of ex-Ukrainian immigrants has developed a portable cardiograph, a wireless ECG recorder, a digital stethoscope, a portable spirometer (measuring lung capacity), a pulse oximeter, blood pressure monitor and glucometer.

Good video summarizing some of Israel’s latest projects to tackle the coronavirus pandemic.

Israel’s MeMed (reported previously) identifies whether an infection is viral or bacterial. MeMed is now working with hospitals in Israel, the Netherlands and elsewhere to identify Covid-19 patients and the potential severity of the infection.

Israel’s Clew Medical (reported previously) has just received US FDA emergency use authorization to remotely identify patients who are likely to experience common coronavirus complications, including respiratory failure and hemodynamic instability.

In a world first, a trial of Ivermectin - an antiparasitic treatment - has been launched at Sheba Medical Center on Covid-19 patients. Ivermectin has been available since 1981 and in the laboratory was recently found to kill the coronavirus within 48 hours.

Israel’s Vectorious Medical Technologies (reported previously) has now patients from Italy, Germany, the UK and Israel, in the trial of its revolutionary in-heart monitor. It is safe and has already detected and prevented pulmonary edema and hospitalization for one elderly UK patient.